Page last updated: 2024-08-18

tetraethylenepentamine and Liver Diseases

tetraethylenepentamine has been researched along with Liver Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hobara, T; Ishiyama, H; Kanbe, Y; Ogino, K; Shimomura, Y; Yamashita, S1

Other Studies

1 other study(ies) available for tetraethylenepentamine and Liver Diseases

ArticleYear
The copper chelating agent tetraethylenepentamine inhibits copper, zinc-superoxide dismutase activity in rat liver: a possible mechanism for its hepatotoxicity.
    Pharmacology & toxicology, 1991, Volume: 69, Issue:3

    Topics: Alanine Transaminase; Animals; Chelating Agents; Chemical and Drug Induced Liver Injury; Drug Administration Routes; Ethylenediamines; Glutathione; Liver; Liver Diseases; Male; Rats; Rats, Inbred Strains; Superoxide Dismutase; Trientine

1991